
moderate, and severe (
6
). However, this classification is itself complex. The VHWG classification,
later modified by Kanters etal; is simpler (
4
;
7
). This too, falls short of accounting for the size of
defect or risk of recurrence. A recent French survey aimed to define “giant” ventral hernias as
those with loss of domain volume of hernia over 30% of abdominal volume (
8
). The European
Hernia Society has developed a platform to record ventral hernia repairs and postoperative
complications. They suggest using the European Hernia Society classification of ventral hernias
based on size and location, which do not accommodate for co-morbidities or the nature of the
hernia defect. They however suggested that institutions using prosthetic meshes should attest to
the safety of the products they use as a recommendation cannot be made in this regard based
on any studies so far considering the various products available in the market. Quality control is
necessary, and it is down to the institutions and surgeons to ensure that (9).
A large population-based study in the US showed that following incisional hernia repair, about 12%
had to undergo further repair in five years, and this figure doubles if no mesh was used (
10
). This
finding was attested by a Dutch multicentre trial comparing suture vs mesh repair of incisional
hernias which found double the number of recurrences in the suture repair group; ( 43% vs
24%) (
11
). Anterior component separation (ACS) is commonly used in bigger defects, with the
repair augmented using various types of meshes. Recurrence rates ranged between 10% to
30% within five years and surgical site infections ranged between 26 to 42%. Biological mesh
compared to soft polypropylene mesh did not add any additional advantage to the strength and
durability of these repairs (
12
). Transversus Abdominis Release (TAR) on the other hand was
found to be useful in repairing bigger defects with even less complications. A recent systematic
review quoted a two-year recurrence rate of 4%, and surgical site occurrence around 15%. The
recurrence is about a third and SSO is nearly half compared to ACS (13).
Thus, it would be fair to say that a standardised approach to complex ventral hernia repair is far
from practical. From, the optimisation of co-morbidities to the type of repair and selection of
meshes, several permutations and combinations are available, each of which could be applied to
a given case depending on the circumstances. Biological meshes, and PADM as discussed in this
paper, are therefore essential tools that should be available in the surgeon’s stockpile. Therefore,
any study about the outcomes of PADM meshes in complex ventral hernias should ideally be
a pragmatic one, and not in a controlled or experimental setting. This is what we have tried to
emulate in this paper.
The recurrence rates following complex ventral hernia repairs using biological meshes have been
reported to be between 12% to 33% and that of wound complications to be between 15% to
40% (
14
;
15
). The present study has shown a recurrence rate of 16% for ventral hernias and 33%
for parastomal hernias. Surgical site occurrences were around 30%. These observations are in
keeping with the available literature. In addition, component separation with PADM (CS/PADM)
was found to be superior to conventional bridged repair, quoting a recurrence rate of 17% for
CS/PADM (
16
). Our cohort showed much less recurrence after CS/PADM, 8%. When considering
biological meshes, there is little to choose between porcine and bovine dermal matrix meshes as
the surgical site occurrences and recurrence rates of hernias were similar (17).
Multicentre blinded trials comparing synthetic mesh with biological mesh showed a three-fold
reduction in hernia recurrence with synthetic mesh in clean contaminated and contaminated fields.
The safety profile and need to return to the theatre were similar, although biological meshes were
significantly costlier (
3
). A recent meta-analysis from Spain has showed no meaningful differ-
ences between mesh types in high-risk ventral hernias, but biosynthetic meshes had favourable
outcomes in terms of reduced recurrence rate of 9% and 14% incidence of SSI (18).
Our study has some obvious drawbacks. Being a retrospective study, the data collection was
not exhaustive, yet we were able to obtain meaningful data regarding BMI and risk factors, ASA
status, and VHWG classification. The lack of standardisation of operating technique and mesh
placement makes comparisons with other similar studies impossible. However, we feel that our
study is more pragmatic and hence likely to reflect the performance of similar institutions in the
United Kingdom. The study represents what came through our doors over the six years and the
outcomes of PADM repair performed in this cohort. This could be taken as a quality control
116/118